211 related articles for article (PubMed ID: 19321434)
1. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.
Leth-Larsen R; Lund R; Hansen HV; Laenkholm AV; Tarin D; Jensen ON; Ditzel HJ
Mol Cell Proteomics; 2009 Jun; 8(6):1436-49. PubMed ID: 19321434
[TBL] [Abstract][Full Text] [Related]
2. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
[TBL] [Abstract][Full Text] [Related]
3. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.
Xie X; Feng S; Vuong H; Liu Y; Goodison S; Lubman DM
Electrophoresis; 2010 Jun; 31(11):1842-52. PubMed ID: 20446291
[TBL] [Abstract][Full Text] [Related]
4. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
5. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
6. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
Xu SG; Yan PJ; Shao ZM
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427
[TBL] [Abstract][Full Text] [Related]
7. Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer.
Erin N; Ogan N; Yerlikaya A
Breast Cancer Res Treat; 2018 Jul; 170(2):235-250. PubMed ID: 29557524
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
9. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.
Whelan SA; Lu M; He J; Yan W; Saxton RE; Faull KF; Whitelegge JP; Chang HR
J Proteome Res; 2009 Aug; 8(8):4151-60. PubMed ID: 19522481
[TBL] [Abstract][Full Text] [Related]
11. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.
Yang T; Xu F; Xu J; Fang D; Yu Y; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():18-24. PubMed ID: 23968647
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins.
Lund RR; Terp MG; Laenkholm AV; Jensen ON; Leth-Larsen R; Ditzel HJ
Proteomics; 2012 Jul; 12(13):2139-48. PubMed ID: 22623409
[TBL] [Abstract][Full Text] [Related]
14. Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression.
Li H; Meng F; Jiang L; Ren Y; Qiu Z; Yu P; Peng J
Life Sci; 2019 Aug; 231():116548. PubMed ID: 31181228
[TBL] [Abstract][Full Text] [Related]
15. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy.
Rasmussen N; Ditzel HJ
J Proteome Res; 2009 Nov; 8(11):5048-59. PubMed ID: 19764822
[TBL] [Abstract][Full Text] [Related]
16. Quantitative LC-MS/MS Analysis of Proteins Involved in Metastasis of Breast Cancer.
Goto R; Nakamura Y; Takami T; Sanke T; Tozuka Z
PLoS One; 2015; 10(7):e0130760. PubMed ID: 26176947
[TBL] [Abstract][Full Text] [Related]
17. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
18. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
Hendrix A; Maynard D; Pauwels P; Braems G; Denys H; Van den Broecke R; Lambert J; Van Belle S; Cocquyt V; Gespach C; Bracke M; Seabra MC; Gahl WA; De Wever O; Westbroek W
J Natl Cancer Inst; 2010 Jun; 102(12):866-80. PubMed ID: 20484105
[TBL] [Abstract][Full Text] [Related]
19. Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis.
Luque-García JL; Martínez-Torrecuadrada JL; Epifano C; Cañamero M; Babel I; Casal JI
Proteomics; 2010 Mar; 10(5):940-52. PubMed ID: 20049862
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.
Xu X; Qiao M; Zhang Y; Jiang Y; Wei P; Yao J; Gu B; Wang Y; Lu J; Wang Z; Tang Z; Sun Y; Wu W; Shi Q
Proteomics; 2010 Apr; 10(7):1374-90. PubMed ID: 20198662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
